Debra Lappin, counsel at Faegre Baker Daniels and president of the Council for American Medical Innovation, will moderate the first panel discussion, "Exploring New Avenues to Accelerate Research," during the 11th annual Indiana Life Sciences Summit on October 15, 2014, in downtown Indianapolis.
Panelists will include Michael D. Clayman, M.D., CEO, Flexion Therapeutics; Annalisa Jenkins, M.D., Chair of the Board of Directors, TransCelerate Biopharma; Jack Phillips, President and CEO, Roche Diagnostics; and Pete Yonkman, President, Cook Medical.
Christopher Austin, M.D., director of the National Institutes of Health's National Center for Advancing Translation Sciences (NCATS), will deliver the keynote address on accelerating research. Leaders from Cook Medical, Roche Diagnostics, Transcelerate BioPharma, Flexion Therapeutics, the State Science and Technology Institute, among others, will be providing their perspectives on topics relevant to Indiana's life sciences industry as well as global trends.
Other panel discussions will focus on "Indiana Biosciences Research Institute's Approach to Quicker Commercialization" and "The Need for Capital and its Impact on Innovation and Research." The second and third panel discussions will be moderated by Gerry Dick, president and managing editor, Grow INdiana Ventures / host and creator of Inside Indiana Business with Gerry Dick.